XML 54 R35.htm IDEA: XBRL DOCUMENT v3.25.2
Segments (Tables)
6 Months Ended 12 Months Ended
Jun. 30, 2025
Dec. 31, 2024
Segments [Line Items]    
Schedule of Other Financial Information Regarding The Company’s Operating Segment See the consolidated condensed financial statements for other financial information regarding the Company’s operating segment.
 

Three Months Ended
June 30,

   

2025

 

2024

Government grant revenue

 

$

 

 

$

25

 

Operating expenses:

 

 

 

 

 

 

 

 

Research personnel compensation costs, including stock-based
compensation

 

 

320

 

 

 

385

 

CRO and regulatory costs

 

 

 

 

 

 

Administrative personnel compensation costs, including stock-based compensation

 

 

401

 

 

 

350

 

Rent and office costs

 

 

118

 

 

 

80

 

Legal and accounting costs

 

 

110

 

 

 

179

 

Other expenses(1)

 

 

54

 

 

 

7

 

Total segment expenses

 

 

1,003

 

 

 

1,001

 

Loss from operations

 

 

(1,003

)

 

 

(976

)

Other income (expense)

 

 

 

 

 

 

 

 

Loss on change in the fair value of related party Tasly convertible debt

 

 

(57

)

 

 

(15

)

Interest expense

 

 

(1,289

)

 

 

(1,081

)

Other income

 

 

1

 

 

 

1

 

Total other expense, net

 

 

(1,345

)

 

 

(1,095

)

Net loss and comprehensive loss

 

$

(2,348

)

 

$

(2,071

)

(1)      Other expenses includes small balances of research materials and supplies along with insurance costs.

 

Six Months Ended
June 30,

   

2025

 

2024

Government grant revenue

 

$

 

 

$

25

 

Operating expenses:

 

 

 

 

 

 

 

 

Research personnel compensation costs, including stock-based compensation

 

 

658

 

 

 

818

 

CRO and regulatory costs

 

 

 

 

 

15

 

Administrative personnel compensation costs, including stock-based compensation

 

 

736

 

 

 

712

 

Rent and office costs

 

 

318

 

 

 

162

 

Legal and accounting costs

 

 

649

 

 

 

592

 

Other expenses(1)

 

 

66

 

 

 

41

 

Total segment expenses

 

 

2,427

 

 

 

2,340

 

Loss from operations

 

 

(2,427

)

 

 

(2,315

)

Other income (expense)

 

 

 

 

 

 

 

 

Loss on change in the fair value of related party Tasly convertible debt

 

 

(118

)

 

 

(11

)

Interest expense

 

 

(2,519

)

 

 

(2,161

)

Other income

 

 

 

 

 

6

 

Total other expense, net

 

 

(2,637

)

 

 

(2,166

)

Net loss and comprehensive loss

 

$

(5,064

)

 

$

(4,481

)

(1)      Other expenses includes small balances of research materials and supplies along with insurance costs.

See the consolidated financial statements for other financial information regarding the Company’s operating segment.
 

Year Ended
December 31,

   

2024

 

2023

Government grant revenue

 

$

100

 

 

$

45

 

Operating expenses:

 

 

 

 

 

 

 

 

Research personnel compensation costs, including stock-based compensation

 

 

1,350

 

 

 

1,641

 

CRO and regulatory costs

 

 

36

 

 

 

186

 

Administrative personnel compensation costs, including stock-based compensation

 

 

1,592

 

 

 

1,434

 

Rent and office costs

 

 

279

 

 

 

365

 

Legal and accounting costs

 

 

1,223

 

 

 

2,287

 

Other expenses(1)

 

 

120

 

 

 

202

 

Total segment expenses

 

 

4,600

 

 

 

6,115

 

Loss from operations

 

 

(4,500

)

 

 

(6,070

)

Other income (expenses)

 

 

 

 

 

 

 

 

Loss on change in the fair value of related party Tasly convertible debt

 

 

(311

)

 

 

(22

)

Interest expense (including related parties amounts of $2,400 and $2,530 for the year ended December 31, 2024 and 2023, respectively)

 

 

(4,424

)

 

 

(4,283

)

Other income

 

 

5

 

 

 

94

 

Total other expense, net

 

 

(4,730

)

 

 

(4,211

)

Net loss and comprehensive loss

 

$

(9,230

)

 

$

(10,281

)

(1)      Other expenses includes small balances of research materials and supplies along with insurance costs.

NorthView Acquisition Corp [Member]    
Segments [Line Items]    
Schedule of Company’s Performance and Making Key Decisions Regarding Resource Allocation When evaluating the Company’s performance and making key decisions regarding resource allocation, the CODM reviews several key metrics included in net loss and total assets, which include the following:
 

As of
June 30,
2025

 

As of
December 31,
2024

Trust Account

 

$

1,935,561

 

$

8,330,835

Cash

 

$

 

$

16,204

Restricted Cash

 

$

1,751

 

$

 

For the Three Months Ended
June 30,

 

For the Six Months Ended
June 30,

   

2025

 

2024

 

2025

 

2024

Formation and operating costs

 

967,084

 

253,130

 

1,550,665

 

723,971

Interest income earned on cash and marketable securities held in Trust Account

 

15,159

 

108,520

 

95,084

 

225,184

When evaluating the Company’s performance and making key decisions regarding resource allocation, the CODM reviews several key metrics included in net (loss) income and total assets, which include the following:
 

For the
Year Ended
December 31,
2024

 

For the
Year Ended
December 31,
2023

Trust Account

 

$

8,330,835

 

$

10,873,406

Cash

 

$

16,204

 

$

4,519

 

For the
Year Ended
December 31,
2024

 

For the
Year Ended
December 31,
2023

General and administrative expenses

 

$

(1,351,038

)

 

$

(1,508,683

)

Interest earned on the Trust Account

 

$

425,416

 

 

$

2,248,538